Cargando…
MCL-1 is modulated in Crohn’s disease fibrosis by miR-29b via IL-6 and IL-8
The miR-29 family is involved in fibrosis in multiple organs, including the intestine where miR-29b facilitates TGF-β-mediated up-regulation of collagen in mucosal fibroblasts from Crohn’s disease (CD) patients. Myeloid cell leukemia-1 (MCL-1), a member of the B-cell CLL/Lymphoma 2 (BCL-2) apoptosis...
Autores principales: | Nijhuis, Anke, Curciarello, Renata, Mehta, Shameer, Feakins, Roger, Bishop, Cleo L., Lindsay, James O., Silver, Andrew |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5397660/ https://www.ncbi.nlm.nih.gov/pubmed/28190086 http://dx.doi.org/10.1007/s00441-017-2576-1 |
Ejemplares similares
-
Epithelial down‐regulation of the miR‐200 family in fibrostenosing Crohn's disease is associated with features of epithelial to mesenchymal transition
por: Mehta, Shameer J., et al.
Publicado: (2018) -
Small-molecule Wnt inhibitors are a potential novel therapy for intestinal fibrosis in Crohns disease
por: Lewis, Amy, et al.
Publicado: (2022) -
The Role of Cytokines in the Fibrotic Responses in Crohn’s Disease
por: Curciarello, Renata, et al.
Publicado: (2017) -
Role of the IL23/IL17 Pathway in Crohn’s Disease
por: Schmitt, Heike, et al.
Publicado: (2021) -
A1 TARGETING IL-4 AND IL-13 TO TREAT CROHN’S DISEASE-ASSOCIATED INTESTINAL FIBROSIS IN SHIP DEFICIENT MICE
por: Safari, K, et al.
Publicado: (2023)